A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema (clinicaltrials.gov) - Sep 26, 2026 - P3 | N=70 | Completed | Sponsor: Incepta Pharmaceuticals Ltd | Recruiting ➔ Completed | Trial completion date: Dec 2025 ➔ May 2026 | Trial primary completion date: Oct 2025 ➔ Mar 2026
Trial completion • Trial completion date • Trial primary completion date • Age-related Macular Degeneration • Diabetic Macular Edema • Diabetic Retinopathy • Macular Degeneration • Ophthalmology • Retinal Disorders
|